This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: DESIGN AND ANTICANCER ACTIVITY PREDICTION OF DIHYROPYRIMIDINONE BASED NOVEL INHIBITORS OF P53-MDM2 INTERACTION, Asian Journal of Pharmaceutical and Clinical Research, September 2017, Innovare Academic Sciences Pvt Ltd,
DOI: 10.22159/ajpcr.2017.v10s4.21346.
You can read the full text:
The following have contributed to this page
